This inventor holds 3 USPTO granted patents. Top assignee: Xeris Pharmaceuticals, Inc.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Innovations by Richard Fitch in Levothyroxine Compositions
Introduction
Richard Fitch is an accomplished inventor based in Chicago, IL (US). He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of stable levothyroxine compositions. His work focuses on improving the stability and efficacy of therapeutic agents used in treating various diseases.
Latest Patents
Richard Fitch holds a patent for "Stable levothyroxine compositions in aprotic polar solvents." This invention involves the use of aprotic polar solvents and an ionization stabilizing agent to create stable therapeutic formulations of levothyroxine. The formulation is designed to treat, prevent, and diagnose certain diseases and disorders in both humans and veterinary animals. The patent outlines methods for preparing these formulations, which include dissolving levothyroxine in an aprotic polar solvent system, such as a DMSO/water admixture, along with one or more additional therapeutic agents.
Career Highlights
Richard Fitch is currently associated with Xeris Pharmaceuticals, Inc., where he continues to innovate in the pharmaceutical sector. His expertise in formulation chemistry has positioned him as a valuable asset in the development of new therapeutic solutions.
Collaborations
Richard has collaborated with Wendy Hu, contributing to the advancement of their shared goals in pharmaceutical research and development.
Conclusion
Richard Fitch's innovative work in stable levothyroxine compositions showcases his commitment to improving therapeutic formulations. His contributions are vital in enhancing treatment options for various medical conditions.